| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/15/2006 | CN1245387C Use of 5-oxy-aporphine alkaloids in making hepatitis virus inhibiting activity drug |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/15/2006 | CN1245215C Recombination high efficiency composite interferon used as hepatitis B surface antigen and e antigen inhibitor |
| 03/15/2006 | CN1245214C Oral liquid containing extration of sturgeon and sturgeon active protein capsule, preparation method therefor |
| 03/15/2006 | CN1245211C Medicine for treating chronic gastritis and peptic ulcer |
| 03/15/2006 | CN1245206C Traditional Chinese medicine for treating pancreatitis |
| 03/15/2006 | CN1245193C Plant leaven with hot and fragrant smell of propylene sulfide and its preparation and use |
| 03/15/2006 | CN1245188C Yi-E-Jing tablets for nourishing kidney and tonifying yang |
| 03/15/2006 | CN1245185C Medicinal composition for treating chronic and prolonged hepatitis |
| 03/15/2006 | CN1245178C Medicine for treating toothache |
| 03/15/2006 | CN1245175C Medicine composition for treating abdominal pain and diarrhea |
| 03/15/2006 | CN1245174C Oral quick disintegration tablet medicine for treating oral ulcer and its preparation method |
| 03/15/2006 | CN1245173C Medicine composition for treating liver fibrillation and liver cirrhosis and its preparation process |
| 03/15/2006 | CN1245171C Yi-E-Jing pills for tonifying yang |
| 03/15/2006 | CN1245157C Novel fatty derivative for treatment of diabetes |
| 03/15/2006 | CN1245155C Oral pharmaceutical pulsed release dosage form |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012145 Method |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012080 Imidazopyridine compounds as 5-HT4 receptor agonists |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | US7012076 Quinazoline-4-sulfonamide derivatives |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7011826 Control of acidosis |
| 03/14/2006 | CA2376748C Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/09/2006 | WO2006025448A1 Method of protecging digestive organ with the use of thioredoxin |
| 03/09/2006 | WO2006025286A1 Constitutional function-improving agents |
| 03/09/2006 | WO2006025072A2 Compounds, compositions, formulations and process for preparation thereof and method of treatment and management of acidity and related disorders |
| 03/09/2006 | WO2006024955A1 Azabicyclic amine histamine-3 receptor antagonists |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052447 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositios comprising them and processes for the preparation of them |
| 03/09/2006 | US20060052413 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/09/2006 | US20060052409 Therapeutic or preventive agent for nausea/vomiting |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 03/09/2006 | US20060052368 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052313 Selective dipeptide inhibitors of kallikrein |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 03/09/2006 | US20060051399 Drugs/foods comprising peptides with high glutamine content produced from wheat gluten; hypercholesterolemia, hypertriglyceridemia, fatty liver, chronic hepatits C |
| 03/09/2006 | US20060051363 Protein inducing cell death of helicobacter pylori |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051314 Drug for prevention and/or treatment of constipation and sympton caused by constipation |
| 03/09/2006 | US20060051296 Thickened beverages for dysphagia |
| 03/09/2006 | DE10019195B4 Reversible Immortalisierung Reversible immortalization |
| 03/09/2006 | CA2578877A1 Pharmaceutical use of graptopetalum and related plants |
| 03/09/2006 | CA2578016A1 Azabicyclic histamine-3 receptor antagonists |
| 03/09/2006 | CA2577284A1 Prostaglandin derivatives for treating gastrointestinal disorder |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632244A1 Preventives or remedies for hepatopathy |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1631306A2 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 03/08/2006 | EP1631305A2 Sincalide formulations |
| 03/08/2006 | EP1631284A2 Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1631145A2 P38 kinase inhibitor compositions and methods of using the same |
| 03/08/2006 | EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1438341B1 Antibody stimulating il-1ra production |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1328285B1 Oral preparation containing seaweed for reduction of plaque and calculus |
| 03/08/2006 | EP1326589B1 Nanoparticles |
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1234576B1 Pharmaceutical composition for eating disorders |
| 03/08/2006 | EP1133991B1 Bacteriostatic compositions for salmonellae |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP0977568B1 Benzocycloheptathiophene compounds |
| 03/08/2006 | EP0733109B1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 03/08/2006 | EP0596049B1 Defoaming composition |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1744896A Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist |
| 03/08/2006 | CN1743334A Methylnaphthohydroquinone diphosphate sodium tablet and its preparing method |
| 03/08/2006 | CN1743312A Fused-polycyclic compounds |
| 03/08/2006 | CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity |